Literature DB >> 26146805

From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML.

M Krumbholz1, J Bradtke2, D Stachel1, O Peters3, B Hero4, W Holter1, R Slany5, M Metzler1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26146805     DOI： 10.1038/bmt.2015.155

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay.

Authors:  Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.

Authors:  M D Megonigal; N K Cheung; E F Rappaport; P C Nowell; R B Wilson; D H Jones; K Addya; D G Leonard; B H Kushner; T M Williams; B J Lange; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion gene.

Authors:  Manuela Krumbholz; Ronny Jung; Jutta Bradtke; Dirk Reinhardt; Daniel Stachel; Markus Metzler
Journal:  Leuk Lymphoma       Date:  2014-07-17

4.  Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials.

Authors:  Thorsten Simon; Frank Berthold; Arndt Borkhardt; Bernhard Kremens; Boris De Carolis; Barbara Hero
Journal:  Pediatr Blood Cancer       Date:  2010-12-09       Impact factor: 3.167

5.  Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.

Authors:  Claus Meyer; Bjoern Schneider; Martin Reichel; Sieglinde Angermueller; Sabine Strehl; Susanne Schnittger; Claudia Schoch; Mieke W J C Jansen; Jacques J van Dongen; Rob Pieters; Oskar A Haas; Theo Dingermann; Thomas Klingebiel; Rolf Marschalek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-30       Impact factor: 11.205

6.  SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling.

Authors:  Ren-Yuan Bai; Christina Koester; Tao Ouyang; Stephan A Hahn; Matthias Hammerschmidt; Christian Peschel; Justus Duyster
Journal:  Nat Cell Biol       Date:  2002-03       Impact factor: 28.824

7.  Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.

Authors:  Gertjan J L Kaspers; Martin Zimmermann; Dirk Reinhardt; Brenda E S Gibson; Rienk Y J Tamminga; Olga Aleinikova; Hortensia Armendariz; Michael Dworzak; Shau-Yin Ha; Henrik Hasle; Liisa Hovi; Alexei Maschan; Yves Bertrand; Guy G Leverger; Bassem I Razzouk; Carmelo Rizzari; Petr Smisek; Owen Smith; Batia Stark; Ursula Creutzig
Journal:  J Clin Oncol       Date:  2013-01-14       Impact factor: 44.544

8.  Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.

Authors:  Blaine W Robinson; Nai-Kong V Cheung; Christos P Kolaris; Suresh C Jhanwar; John K Choi; Neil Osheroff; Carolyn A Felix
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

9.  The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21).

Authors:  Sabine Strehl; Arndt Borkhardt; Robert Slany; Uta E Fuchs; Margit König; Oskar A Haas
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

10.  Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.

Authors:  Ryan J Whitmarsh; Charles Saginario; Ya Zhuo; Eva Hilgenfeld; Eric F Rappaport; Maureen D Megonigal; Martin Carroll; Mingli Liu; Neil Osheroff; Nai-Kong V Cheung; Diana J Slater; Thomas Ried; Turid Knutsen; Ian A Blair; Carolyn A Felix
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867
View more
  3 in total

1.  Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia.

Authors:  Heiko Becker; Gabriele Greve; Keisuke Kataoka; Jan-Philipp Mallm; Jesús Duque-Afonso; Tobias Ma; Christoph Niemöller; Milena Pantic; Justus Duyster; Michael L Cleary; Julia Schüler; Karsten Rippe; Seishi Ogawa; Michael Lübbert
Journal:  Blood Adv       Date:  2019-03-12

2.  Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.

Authors:  Tim H H Coorens; Grace Collord; Wanhua Lu; Emily Mitchell; Jannat Ijaz; Thomas Roberts; Thomas R W Oliver; G A Amos Burke; Michael Gattens; Emmy Dickens; Jyoti Nangalia; Marc Tischkowitz; John Anderson; Adam Shlien; Anna L Godfrey; Matthew J Murray; Sam Behjati
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

3.  Prognostic Significance of Mixed-Lineage Leukemia (MLL) Gene Detected by Real-Time Fluorescence Quantitative PCR Assay in Acute Myeloid Leukemia.

Authors:  Sai Huang; Hua Yang; Yan Li; Cong Feng; Li Gao; Guo-Feng Chen; Hong-Hao Gao; Zhi Huang; Yong-Hui Li; Li Yu
Journal:  Med Sci Monit       Date:  2016-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.